Cancer, Advanced Terminated Phase 1 Trials for Gemcitabine (DB00441)

Also known as: Advanced Cancer / Cancer / Neoplasm malignant / Malignant neoplasm NOS / Cancer NOS / Malignant tumor / Malignant tumour / Cancer (NOS) / Malignant neoplasm without specification of site

IndicationStatusPhase
DBCOND0041606 (Cancer, Advanced)Terminated1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01929941An Open-Label Study of a Novel JAK-inhibitor, INCB047986, Given in Patients With Advanced MalignanciesTreatment